Trial Profile
A prospective, open, randomized, multicenter study comparing the effects of everolimus versus mycophenolate sodium as compared to ciclosporin as maintenance therapy in renal allograft recipients, on chronic allograft damage and cardiovascular parameters.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary) ; Mycophenolate sodium (Primary) ; Prednisolone
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms MECANO
- 17 Sep 2016 Results published in the American Journal of Transplantation
- 17 Sep 2016 Primary endpoint has been met. (Degree of inflammation and fibrosis and degree of arteriolar hyalinosis in renal biopsies taken at 6 and 24 months after implantation for prednisolone/Everolimus (P/EVL) arm), according to Results published in the American Journal of Transplantation.
- 17 Sep 2016 Results published in the American Journal of Transplantation